Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Pinto

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Neurourology and Urodynamics|August 26, 2017
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluationAngelo Totaro, Francesco Pinto, Dario Pugliese, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|August 23, 2012
Hot topics in urological health economics. A mini reviewMarco Racioppi, Giuseppe Palermo, Alessandro D'Addessi, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 1, 2011
The prognostic role of evoked potentials in neonatal hypoxic-ischemic insultSilvia Lori, Giovanna Bertini, Elisabetta Molesti, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|May 31, 2019
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expressionGiuseppe Palermo, Pierfrancesco Bassi, Marco Racioppi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|November 29, 2007
The cost of treatment and follow-up of bladder cancer in ItalyMarco Racioppi, Andrea Volpe, Roberto Falabella, et al.
Oncology Reports|May 4, 2012
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomyFortunata Iacopino, Francesco Pinto, Alessandro Bertaccini, et al.
Urologia|March 6, 2012
[Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis]Gaetano Gulino, Michele Antonucci, Giuseppe Palermo, et al.
Urologia|August 7, 2012
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary resultsAlessandro Calarco, Francesco Pinto, Francesco Pierconti, et al.
BJU International|June 21, 2012
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort studyEmilio Sacco, Riccardo Bientinesi, Francesco Marangi, et al.
Open Access Journal of Urology|November 8, 2013
Social, economic, and health utility considerations in the treatment of overactive bladderEmilio Sacco, Daniele Tienforti, Alessandro D'Addessi, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Neurourology and Urodynamics|August 26, 2017
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluationAngelo Totaro, Francesco Pinto, Dario Pugliese, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|August 23, 2012
Hot topics in urological health economics. A mini reviewMarco Racioppi, Giuseppe Palermo, Alessandro D'Addessi, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 1, 2011
The prognostic role of evoked potentials in neonatal hypoxic-ischemic insultSilvia Lori, Giovanna Bertini, Elisabetta Molesti, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|May 31, 2019
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expressionGiuseppe Palermo, Pierfrancesco Bassi, Marco Racioppi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|November 29, 2007
The cost of treatment and follow-up of bladder cancer in ItalyMarco Racioppi, Andrea Volpe, Roberto Falabella, et al.
Oncology Reports|May 4, 2012
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomyFortunata Iacopino, Francesco Pinto, Alessandro Bertaccini, et al.
Urologia|March 6, 2012
[Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis]Gaetano Gulino, Michele Antonucci, Giuseppe Palermo, et al.
Urologia|August 7, 2012
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary resultsAlessandro Calarco, Francesco Pinto, Francesco Pierconti, et al.
BJU International|June 21, 2012
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort studyEmilio Sacco, Riccardo Bientinesi, Francesco Marangi, et al.
Open Access Journal of Urology|November 8, 2013
Social, economic, and health utility considerations in the treatment of overactive bladderEmilio Sacco, Daniele Tienforti, Alessandro D'Addessi, et al.
Pageof 11